BCL2L1 and breast neoplasm: Querying the TCGA database for BCL2L1 amplification in primary breast tumors revealed that 430/1105 (39%) samples harbor BCL2L1 copy number gain and 23/1105 (2%) harbor a high-level focal amplification as determined by GISTIC (Figure 1C).